Profile
Scott Filosi is currently the Chief Executive Officer at Diaccurate SA since 2023.
He also holds a current position as the Head-Global Market Access & Pricing at Merck KGaA.
Previously, he worked at Merck KGaA as the Head-Global Market Access & Pricing.
Scott Filosi active positions
| Companies | Position | Start |
|---|---|---|
Diaccurate SA
 Diaccurate SA Medical SpecialtiesHealth Technology Diaccurate SASU engages in the research of diagnostic products. It offers diagnostic products especially in the field of theranostics. The firm operates as a biopharmaceutical company that engages in developing new therapies for the treatment of HIV infection. The company was founded in 2012 and is headquartered in Paris, France. | Chief Executive Officer | 06/11/2023 |
Former positions of Scott Filosi
| Companies | Position | End |
|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | 01/05/2019 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MERCK KGAA | Health Technology |
| Private companies | 1 |
|---|---|
Diaccurate SA
Diaccurate SA Medical SpecialtiesHealth Technology Diaccurate SASU engages in the research of diagnostic products. It offers diagnostic products especially in the field of theranostics. The firm operates as a biopharmaceutical company that engages in developing new therapies for the treatment of HIV infection. The company was founded in 2012 and is headquartered in Paris, France. | Health Technology |
- Stock Market
- Insiders
- Scott Filosi
